Pharvaris NV
F:9EN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharvaris NV
F:9EN
|
NL |
|
P
|
Patterson-UTI Energy Inc
DUS:PE1
|
US |
|
S
|
Sprint Bioscience AB
XMUN:5JA1
|
SE |
|
C
|
Capital One Financial Corp
F:CFX
|
US |
|
O
|
ON Semiconductor Corp
F:XS4
|
US |
|
Keppel REIT
F:H27
|
SG |
|
K
|
Kering SA
DUS:PPX
|
FR |
|
W
|
Wharf Holdings Ltd
OTC:WARFF
|
HK |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
US |
|
S
|
SISB PCL
SET:SISB
|
TH |
|
C
|
Compagnie de Saint Gobain SA
F:GOB
|
FR |
|
C
|
Computacenter PLC
F:COUD
|
UK |
|
P
|
Pilgrims Pride Corp
XBER:6PP
|
US |
|
H
|
HSBC Holdings PLC
XMUN:HBC2
|
UK |
|
E
|
Equifax Inc
DUS:EFX
|
US |
|
W
|
Wartsila Oyj Abp
OTC:WRTBY
|
FI |
|
Eltel AB
STO:ELTEL
|
SE |
|
V
|
Vita 34 AG
DUS:V3V
|
DE |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
IN |
|
Airports of Thailand PCL
SET:AOT
|
TH |
|
Stem Inc
NYSE:STEM
|
US |
Bankruptcy Probability
Pharvaris NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pharvaris NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
Pharvaris NV
NASDAQ:PHVS
|
2.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
634.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
311.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
275.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pharvaris NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pharvaris NV has total debt of 576.6k EUR. This includes both short-term (0 EUR) and long-term (576.6k EUR) debt.
You can find a full breakdown on its Balance Sheet.
